September 25, 2024
TOPLINE: The prevalence of diabetes in the United States increased by 18.6% from 2012 to 2022, with notably higher rates among racial and ethnic minorities, men, […]
September 25, 2024
TOPLINE: In patients with rectal cancer, having persistent lymph node metastases after neoadjuvant chemoradiotherapy is associated with worse overall survival outcomes and higher rates of recurrence […]
September 24, 2024
TOPLINE: Patients with breast cancer carrying TP53 pathogenic variants face an 8.8% cumulative risk for developing sarcoma within 15 years of receiving radiotherapy. However, the 10-year […]
September 24, 2024
TOPLINE: Maternal short sleep duration during pregnancy is linked to an increased risk for neurodevelopmental delays in offspring, particularly in boys. The study suggests that higher […]
September 24, 2024
TOPLINE: The prevalence of obesity among US adults is 40.3%, and the prevalence of severe obesity is 9.4%, according to the latest data (2021-2023) from the […]
September 23, 2024
TOPLINE: The US Food and Drug Administration (FDA) has issued 510(k) clearance to See-Mode Technologies for their AI-based thyroid ultrasound analysis and reporting software. While various […]
September 23, 2024
TOPLINE: Medicare Advantage plans had lower adjusted total resource use than traditional Medicare for patients with cancer undergoing chemotherapy, with no difference in 18-month survival between […]
September 23, 2024
TOPLINE: Black women in the United States have higher breast cancer (BC) mortality rates than White women across tumor subtypes. The greatest disparity in BC-specific survival […]
September 23, 2024
TOPLINE: Metabolic/bariatric surgery (MBS) reduces thyroid-stimulating hormone (TSH), free triiodothyronine (fT3) levels, and thyroid hormone resistance indices in patients with obesity, changes strongly correlated with improvement […]